Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-66.56%Operating Cash Flow Margin
VS
Market
Sector
Industry
History
$ 2.21Close
$ 0.56 - $ 3.04 52-Week Range
Ticker Information
Ticker
SPROCompany Name
SPERO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSPERO THERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SPRO - OCF % Historical data
| Date | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -32.33M | -66.56% | $ 48.58M |
| 3/31/2025 | $ -33.38M | -74.88% | $ 44.58M |
| 12/31/2024 | $ -23.44M | -48.87% | $ 47.98M |
| 9/30/2024 | $ -17.54M | -16.47% | $ 106.45M |
| 6/30/2024 | $ -14.38M | -12.14% | $ 118.46M |
| 3/31/2024 | $ -14.2M | -12.8% | $ 110.98M |
| 12/31/2023 | $ -32.99M | -31.79% | $ 103.78M |
| 9/30/2023 | $ 28.98M | 37.3% | $ 77.7M |
| 6/30/2023 | $ 12.11M | 22.33% | $ 54.23M |
| 3/31/2023 | $ 7.64M | 14.28% | $ 53.51M |
Key Performance Insights, Last 5 Years
- SPERO THERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at -785.81%.
- Over the past 5 years, SPERO THERAPEUTICS INC's average OCF % has been -290.65%.
- The median OCF % for SPERO THERAPEUTICS INC during this period was -70.72%
- SPERO THERAPEUTICS INC reached its highest OCF % over the past 5 years at 37.3%.
- The lowest OCF % recorded by SPERO THERAPEUTICS INC in the same timeframe -920.39%
SPERO THERAPEUTICS INC's OCF % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
OCF % Benchmarks
Similar metrics to Revenues:
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Operating Cash Flow Margin
[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].CF - Operations / Revenues
(=) OCF % OCF % for SPERO THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -86.86M ] / Revenues [ $ 11.05M ]
(=) OCF % [ -785.81% ] SPRO - Operating Cash Flow Margin, Last 5 years
-920.39%
Minimum
Dec 31, 2020
37.3%
Maximum
Sep 30, 2023
-290.65%
Average
-70.72%
Median
OCF % Benchmark AnalysisMarket
The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
| filtered constituents | 3.25K |
|---|---|
| min | -57.27% |
| max | 77.08% |
| average | 14.31% |
| median | 12.65% |
| std | 21.13% |